協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/06/12 | 2,471 | 2,497 | 2,463 | 2,489.5 | +12 | +0.5% | 903,600 |
2025/06/11 | 2,487 | 2,494 | 2,461.5 | 2,477.5 | +14.5 | +0.6% | 904,900 |
2025/06/10 | 2,450 | 2,463.5 | 2,434 | 2,463 | +4 | +0.2% | 997,900 |
2025/06/09 | 2,463 | 2,487 | 2,450.5 | 2,459 | +25 | +1% | 794,400 |
2025/06/06 | 2,475 | 2,477.5 | 2,428.5 | 2,434 | -31 | -1.3% | 1,094,200 |
2025/06/05 | 2,447 | 2,488.5 | 2,432 | 2,465 | +82.5 | +3.5% | 1,782,300 |
2025/06/04 | 2,375.5 | 2,397.5 | 2,368.5 | 2,382.5 | +2.5 | +0.1% | 1,020,500 |
2025/06/03 | 2,345.5 | 2,383.5 | 2,313 | 2,380 | +17.5 | +0.7% | 1,302,200 |
2025/06/02 | 2,372.5 | 2,447 | 2,346.5 | 2,362.5 | +9 | +0.4% | 1,972,900 |
2025/05/30 | 2,260 | 2,355.5 | 2,252 | 2,353.5 | +94 | +4.2% | 2,858,900 |
2025/05/29 | 2,261 | 2,293 | 2,257 | 2,259.5 | +5 | +0.2% | 1,143,100 |
2025/05/28 | 2,242 | 2,274 | 2,235.5 | 2,254.5 | +16 | +0.7% | 806,300 |
2025/05/27 | 2,243.5 | 2,248 | 2,221 | 2,238.5 | +11.5 | +0.5% | 913,200 |
2025/05/26 | 2,197.5 | 2,256.5 | 2,187.5 | 2,227 | +24.5 | +1.1% | 970,400 |
2025/05/23 | 2,230 | 2,239 | 2,187 | 2,202.5 | -33 | -1.5% | 1,082,900 |
2025/05/22 | 2,235 | 2,256 | 2,222.5 | 2,235.5 | +2.5 | +0.1% | 1,186,100 |
2025/05/21 | 2,227.5 | 2,251.5 | 2,217.5 | 2,233 | +55.5 | +2.5% | 1,057,900 |
2025/05/20 | 2,248.5 | 2,254 | 2,172.5 | 2,177.5 | -77 | -3.4% | 1,265,900 |
2025/05/19 | 2,249 | 2,283 | 2,243 | 2,254.5 | +43.5 | +2% | 1,120,900 |
2025/05/16 | 2,188.5 | 2,219 | 2,167 | 2,211 | +38.5 | +1.8% | 1,011,800 |
2025/05/15 | 2,158 | 2,175 | 2,145 | 2,172.5 | -2 | -0.1% | 991,200 |
2025/05/14 | 2,191.5 | 2,202.5 | 2,155 | 2,174.5 | -43.5 | -2% | 1,186,800 |
2025/05/13 | 2,205.5 | 2,245 | 2,181.5 | 2,218 | +78 | +3.6% | 1,573,100 |
2025/05/12 | 2,228 | 2,228 | 2,121 | 2,140 | -64 | -2.9% | 1,631,200 |
2025/05/09 | 2,229 | 2,230 | 2,185.5 | 2,204 | +14.5 | +0.7% | 1,676,500 |
2025/05/08 | 2,108.5 | 2,237 | 2,100 | 2,189.5 | +98 | +4.7% | 3,027,400 |
2025/05/07 | 2,123 | 2,132 | 2,091.5 | 2,091.5 | -99.5 | -4.5% | 2,037,900 |
2025/05/02 | 2,135 | 2,256.5 | 2,135 | 2,191 | -47.5 | -2.1% | 2,935,200 |
2025/05/01 | 2,220 | 2,241.5 | 2,191 | 2,238.5 | +13.5 | +0.6% | 760,900 |
2025/04/30 | 2,222 | 2,230 | 2,207 | 2,225 | +28.5 | +1.3% | 1,231,700 |
2025/04/28 | 2,185 | 2,217.5 | 2,185 | 2,196.5 | -2.5 | -0.1% | 781,600 |
2025/04/25 | 2,219 | 2,219 | 2,187.5 | 2,199 | ±0 | ±0% | 911,200 |
2025/04/24 | 2,206.5 | 2,214.5 | 2,187.5 | 2,199 | -13.5 | -0.6% | 558,700 |
2025/04/23 | 2,238 | 2,239.5 | 2,199.5 | 2,212.5 | +12.5 | +0.6% | 844,800 |
2025/04/22 | 2,222 | 2,222 | 2,181 | 2,200 | +4 | +0.2% | 649,600 |
2025/04/21 | 2,220.5 | 2,225 | 2,192 | 2,196 | -8 | -0.4% | 891,500 |
2025/04/18 | 2,193.5 | 2,218.5 | 2,179 | 2,204 | +10 | +0.5% | 944,000 |
2025/04/17 | 2,187.5 | 2,194 | 2,162 | 2,194 | -9 | -0.4% | 1,487,300 |
2025/04/16 | 2,172 | 2,209 | 2,152 | 2,203 | +35 | +1.6% | 1,144,100 |
2025/04/15 | 2,170 | 2,178 | 2,153.5 | 2,168 | +19.5 | +0.9% | 917,100 |
2025/04/14 | 2,118 | 2,175.5 | 2,118 | 2,148.5 | +63.5 | +3% | 1,295,500 |
2025/04/11 | 2,071 | 2,105 | 2,034 | 2,085 | -36 | -1.7% | 1,865,600 |
2025/04/10 | 2,142.5 | 2,144 | 2,067 | 2,121 | +68.5 | +3.3% | 1,420,300 |
2025/04/09 | 2,079.5 | 2,094 | 2,037 | 2,052.5 | -23.5 | -1.1% | 1,594,200 |
2025/04/08 | 2,106.5 | 2,107 | 2,050 | 2,076 | +3 | +0.1% | 1,325,500 |
2025/04/07 | 2,076.5 | 2,119.5 | 2,037.5 | 2,073 | -131 | -5.9% | 1,785,800 |
2025/04/04 | 2,121.5 | 2,223 | 2,121.5 | 2,204 | +84.5 | +4% | 1,915,800 |
2025/04/03 | 2,111 | 2,127.5 | 2,100.5 | 2,119.5 | -10 | -0.5% | 1,177,300 |
2025/04/02 | 2,191 | 2,205 | 2,127 | 2,129.5 | -34 | -1.6% | 1,126,600 |
2025/04/01 | 2,166.5 | 2,181.5 | 2,144.5 | 2,163.5 | -9.5 | -0.4% | 1,363,600 |
1~
50
件表示中 / 3719件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 248,900円 | -3.5% | -11.3% | 2.41% | 22.86倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
アステラス薬 | 141,600円 | +0.9% | +380.2% | 5.51% | 19.50倍 | 1.68倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 245,800円 | +20.9% | +10.6% | 2.69% | 11.62倍 | 1.54倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 412,800円 | +0.1% | -3.4% | 3.88% | 28.06倍 | 1.38倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 157,900円 | +0.6% | +43.3% | 5.07% | 11.07倍 | 0.95倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム